GGrantIndex
Sort

78,016 grants matching breast cancer

COHORT MANAGEMENT

$578,205
Patricia L Blount · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA

Breast Cancer:Education, Counseling, and Adjustment

$578,194
New York University · R01 · FY2004 · CA

Faith Moves Mountains: A CBPR Appalachian Wellness & Cancer Prevention Program

$578,187
Nancy E Schoenberg · University Of Kentucky · R24 · FY2009 · MD

Descriptive Studies and Record Linkage

$578,176
Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

Evolutionary/Adaptive Factors in Breast Cancer in African-Americans

$578,149
Christine B. Ambrosone · Roswell Park Cancer Institute Corp · P01 · FY2013 · CA

A value affirmation intervention for physical symptoms and medication adherence in breast cancer patients taking aromatase inhibitors

$578,139
John David Creswell · Carnegie-Mellon University · R01 · FY2020 · CA

VITAMIN K-MEDIATED CARBOXYLATION IN BREAST CANCER

$578,122
Research Foundation For The State University Of New York, The · · FY2016 · Department of the Army

Testing scalable, IVR-supported cancer prevention interventions in the rural Alabama Black Belt

$578,114
Dorothy W. Pekmezi · University Of Alabama At Birmingham · R01 · FY2022 · CA

Testing scalable, IVR-supported cancer prevention interventions in the rural Alabama Black Belt

$578,114
Dorothy W. Pekmezi · University Of Alabama At Birmingham · R01 · FY2023 · CA

Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice

$578,095
Gregory R J Thatcher · University Of Illinois At Chicago · R01 · FY2017 · AG

OPTICAL CHERENKOV IMAGING DOSIMETRY IN HUMAN RADIOTHERAPY

$578,087
Brian William Pogue · University Of Wisconsin-Madison · R01 · FY2024 · EB

Novel Targeted Therapy for Breast Cancer

$578,078
Ginette Serrero · A And G Pharmaceutical, Inc. · R44 · FY2011 · CA

Project 1:The Carolina Breast Cancer Study

$578,056
Melissa A. Troester · Univ Of North Carolina Chapel Hill · P50 · FY2020 · CA

Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis

$578,041
Efstathios Karathanasis · Case Western Reserve University · R01 · FY2023 · CA

Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer

$578,023
Laura Carpin Kennedy · Vanderbilt University Medical Center · R01 · FY2025 · CA

Profiling the Fluid Assisted Dissemination of Pre-malignant cells in Fallopian Tubes

$578,012
Geeta Mehta · University Of Michigan At Ann Arbor · R37 · FY2024 · CA

SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)

$577,988
University Of Pennsylvania · R24 · FY2003 · CA

High-resolution lower dose dedicated breast CT

$577,984
Srinivasan Vedantham · University Of Arizona · R01 · FY2020 · CA

COOPERATIVE FAMILY REGISTRY FOR BREAST CANCER STUDY

$577,947
Fox Chase Cancer Center · U01 · FY2003 · CA

A NOVEL THERAPEUTIC STRATEGY TARGETING BACH1 FOR TRIPLE-NEGATIVE BREAST CANCER

$577,942
University Of Chicago · · FY2017 · Department of the Army

Metabolic Targets in Pten-Tumors

$577,897
Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA

Core - Biomarker Developmental Laboratory (BDL)

$577,873
Amanda G Paulovich · Fred Hutchinson Cancer Center · U2C · FY2023 · CA

AUTONOMIC NERVOUS SYSTEM ACTIVITY AND THE IMPLICATIONS IN BREAST CANCER METASTASIS

$577,819
Case Western Reserve University · · FY2018 · Defense Health Agency

Huntsman Cancer Institute/Univ of Utah Network Lead Academic Participating Site

$577,726
David K Gaffney · University Of Utah · U10 · FY2017 · CA

Understanding breast cancer progression as a defect in the mechanics of tissue self-organization

$577,726
Zev Jordan Gartner · University Of California, San Francisco · U01 · FY2021 · CA